Is ABSI a good stock to buy? We came across a bullish thesis on Absci Corporation on TradersPro's Substack. In this article, we will summarize the bulls' thesis on ABSI. Absci Corporation's share was trading at $7.27 as of June 15th.
Pressmaster/Shutterstock.com
Absci Corporation (ABSI) is a clinical-stage biopharmaceutical company focused on transforming drug discovery through the use of generative artificial intelligence, positioning itself at the forefront of a rapidly growing trend toward AI-enabled drug development. The company's lead program, ABS-201, is an antibody-based therapy designed to treat androgenetic alopecia, or pattern hair loss, by targeting a protein pathway involved in hair follicle biology.
Read More: 15 AI Stocks That Are Quietly Making Investors Rich
Read More: Undervalued AI Stock Poised For Massive Gains: 10000% Upside Potential
Pressmaster/Shutterstock.com
Absci Corporation (ABSI) is a clinical-stage biopharmaceutical company focused on transforming drug discovery through the use of generative artificial intelligence, positioning itself at the forefront of a rapidly growing trend toward AI-enabled drug development. The company's lead program, ABS-201, is an antibody-based therapy designed to treat androgenetic alopecia, or pattern hair loss, by targeting a protein pathway involved in hair follicle biology.
Read More: 15 AI Stocks That Are Quietly Making Investors Rich
Read More: Undervalued AI Stock Poised For Massive Gains: 10000% Upside Potential
7 hours ago
